Add to ORKGwww.fsp.usp.br/rsp HTLV-I/II and blood donors: determinants associated with seropositivity in a low risk population HTLV-I/II e doadores de sangue: determinantes associados à soropositividade em população de baixo risc
How to handle Western blot (WB) seroindeterminate individuals for Human T-lymphotropic Virus 1/2 (HT...
It is unknown whether HTLV-1/2 prevalence has been stable or changing with time in Brazil. We presen...
It is unknown whether HTLV-1/2 prevalence has been stable or changing with time in Brazil. We presen...
OBJECTIVE: Blood donors in Brazil have been routinely screened for HTLV-I/II since 1993. A study was...
OBJECTIVE: Blood donors in Brazil have been routinely screened for HTLV-I/II since 1993. A study was...
Ministério da Saúde. Fundação Nacional de Saúde. Instituto Evandro Chagas. Belém, PA, Brasil.Ministé...
OBJECTIVE: Blood donors in Brazil have been routinely screened for HTLV-I/II since 1993. A study was...
ABSTRACTBackgroundInfection with human T-lymphotropic virus 1 or 2 (HTLV-1/2) is a major health prob...
Background: Infection with human T-lymphotropic virus 1 or 2 (HTLV-1/2) is a major health problem. T...
SummaryObjectiveTo identify HTLV-II prevalence in blood donors at the Blood Center Net of Ceará (Hem...
How to handle Western blot (WB) seroindeterminate individuals for Human T-lymphotropic Virus 1/2 (HT...
The seroprevalence and geographic distribution of HTLV-1/2 among blood donors are extremely importan...
The seroprevalence and geographic distribution of HTLV-1/2 among blood donors are extremely importan...
Human T-lymphotropic virus type 1/2 (HTLV-1/2) infection is endemic in Brazil but representative don...
type I among blood donors: a nationwide Brazilian study Previous studies have demonstrated the prese...
How to handle Western blot (WB) seroindeterminate individuals for Human T-lymphotropic Virus 1/2 (HT...
It is unknown whether HTLV-1/2 prevalence has been stable or changing with time in Brazil. We presen...
It is unknown whether HTLV-1/2 prevalence has been stable or changing with time in Brazil. We presen...
OBJECTIVE: Blood donors in Brazil have been routinely screened for HTLV-I/II since 1993. A study was...
OBJECTIVE: Blood donors in Brazil have been routinely screened for HTLV-I/II since 1993. A study was...
Ministério da Saúde. Fundação Nacional de Saúde. Instituto Evandro Chagas. Belém, PA, Brasil.Ministé...
OBJECTIVE: Blood donors in Brazil have been routinely screened for HTLV-I/II since 1993. A study was...
ABSTRACTBackgroundInfection with human T-lymphotropic virus 1 or 2 (HTLV-1/2) is a major health prob...
Background: Infection with human T-lymphotropic virus 1 or 2 (HTLV-1/2) is a major health problem. T...
SummaryObjectiveTo identify HTLV-II prevalence in blood donors at the Blood Center Net of Ceará (Hem...
How to handle Western blot (WB) seroindeterminate individuals for Human T-lymphotropic Virus 1/2 (HT...
The seroprevalence and geographic distribution of HTLV-1/2 among blood donors are extremely importan...
The seroprevalence and geographic distribution of HTLV-1/2 among blood donors are extremely importan...
Human T-lymphotropic virus type 1/2 (HTLV-1/2) infection is endemic in Brazil but representative don...
type I among blood donors: a nationwide Brazilian study Previous studies have demonstrated the prese...
How to handle Western blot (WB) seroindeterminate individuals for Human T-lymphotropic Virus 1/2 (HT...
It is unknown whether HTLV-1/2 prevalence has been stable or changing with time in Brazil. We presen...
It is unknown whether HTLV-1/2 prevalence has been stable or changing with time in Brazil. We presen...